Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Erin M. Fedak Romanowski"'
Autor:
Zachary M. Grinspan, Daniel W. Shrey, Jason Coryell, Priya Tatachar, Jeffrey Bolton, Ernesto Gonzalez-Giraldo, Samir Karia, Rani K. Singh, Nancy A. McNamara, Michael Scott Perry, Dewi F. Depositario-Cabacar, Erin M. Fedak Romanowski, Michael A. Ciliberto, Max Perelman, Lily C. Wong-Kisiel, Sabrina Shandley, Krista Eschbach, Kumar Sannagowdara, Adam P. Ostendorf, Joseph Sullivan, Shilpa B Reddy, Satyanarayana Gedela, Ahmad Marashly, Srishti Nangia, Patel Shital, Patricia E. McGoldrick, Allyson Alexander, Steven M. Wolf
Publikováno v:
EpilepsiaREFERENCES. 63(1)
Drug-resistant epilepsy (DRE) occurs at higher rates in children3 years old. Epilepsy surgery is effective, but rarely utilized in young children despite developmental benefits of early seizure freedom. The present study aims to identify unique patie
Autor:
Daniel G. Whitney, Erin M. Fedak Romanowski, Chamith S. Rajapakse, Edward A. Hurvitz, Michelle S. Caird
Publikováno v:
EpilepsiaReferences. 62(9)
Objective The objective of this study was to determine whether two commonly prescribed antiseizure medications (ASMs), levetiracetam (LEV) and oxcarbazepine (OXC), were associated with an increased risk of fragility fracture in children with epilepsy
Autor:
Rachel Gottlieb-Smith, Nancy A. McNamara, Erin E Neil, Louis T. Dang, Erin M. Fedak Romanowski
Publikováno v:
The Journal of pediatrics. 229
Autor:
Steven M. Leber, Louis T. Dang, Patricia L. Robertson, Sucheta M. Joshi, Renée A. Shellhaas, Martha D. Carlson, Julie Sturza, Garnett C. Smith, Julie Ziobro, Erin M. Fedak Romanowski, Nancy A. McNamara
Publikováno v:
Epilepsia. 61
In January 2019, a new plant-derived purified cannabidiol preparation, approved by the US Food and Drug Administration, became commercially available for patients ≥2 years old with Lennox-Gastaut syndrome or Dravet syndrome. Among our patients who
Implementation of a Standardized Seizure Action Plan to Improve Communication and Parental Education
Publikováno v:
Pediatric neurology. 112
Quality measures have highlighted the need for efficient treatment of status epilepticus. One strategy is prevention of refractory status epilepticus through individualized seizure action plans. As a quality improvement project, we implemented a stan
Publikováno v:
Seminars in Pediatric Neurology. 39:100928
To perform a systematic review evaluating reported outcomes for epilepsy surgery in pediatric patients with pharmacoresistant epilepsy beyond seizure control, including impact on quality of life, behavioral, neurocognitive outcomes as well as complic
Autor:
Karl J. Jepsen, Chamith S. Rajapakse, Erin M. Fedak Romanowski, Vivek Kalia, Michelle S. Caird, Edward A. Hurvitz, Daniel G. Whitney
Publikováno v:
Bone. 149:115996
Background Anti-seizure medication (ASM) is necessary to manage epilepsy and often prescribed to children and adolescents, but can lead to iatrogenic effects, including bone fragility by altering bone metabolism. Disrupting bone metabolism during cru
Autor:
Erin M. Fedak Romanowski
Publikováno v:
Seminars in Pediatric Neurology. 38:100898
As pediatric epilepsy surgery cases increase in number and complexity, there remains a paucity of data regarding how, when, and in whom to discontinue antiseizure medications postoperatively. The "TimeToStop" data has been influential to clinical pra
Publikováno v:
Seminars in pediatric neurology. 24(4)
Antiseizure medications and dietary therapies have associated effects on the endocrine system. We provided an overview of the relationship between epilepsy treatment and bone health in children with epilepsy. Additionally, we discussed the effects of